zzzs
Publications
-
Blood ordering from the operating room: turnaround time as a quality indicator.
McClain CM,
Hughes J, Andrews JC, Blackburn J, Sephel S, France D, Viele M, Goodnough LT, Young PP.
Transfusion.
2013;
53
(1):
41-8
-
Current status of pharmacologic therapies in patient blood management.
Goodnough LT,
Shander A.
Anesth Analg.
2013;
116
(1):
15-34
-
In reply.
Goodnough LT,
Shander A.
Anesthesiology.
2013;
118
(1):
223-4
-
Logistics of transfusion support for patients with massive hemorrhage.
Goodnough LT,
Spain DA, Maggio P.
Curr Opin Anaesthesiol.
2013;
26
(2):
208-14
-
Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis.
Goodnough LT,
Smith PK, Levy JH, Poston RS, Short MA, Weerakkody GJ, LeNarz LA.
J Thorac Cardiovasc Surg.
2013;
145
(4):
1077-1082.e4
-
Update on erythropoiesis-stimulating agents.
Goodnough LT,
Shander A.
Best Pract Res Clin Anaesthesiol.
2013;
27
(1):
121-9
-
A novel allocation strategy for blood transfusions: investigating the tradeoff between the age and availability of transfused blood.
Atkinson MP,
Fontaine MJ, Goodnough LT, Wein LM.
Transfusion.
2012;
52
(1):
108-17
-
A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management.
Goodnough LT,
Crit Care Clin.
2012;
28
(3):
413-26, vi-vii
-
How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
Fontaine MJ,
Mills AM, Weiss S, Hong WJ, Viele M, Goodnough LT.
Transfusion.
2012;
52
(10):
2081-5
-
Invited commentary.
Goodnough LT,
Levy JH.
Ann Thorac Surg.
2012;
94
(3):
709
-
Iron deficiency syndromes and iron-restricted erythropoiesis (CME).
Goodnough LT,
Transfusion.
2012;
52
(7):
1584-92
-
Operational, quality, and risk management in the transfusion service: lessons learned.
Goodnough LT,
Transfus Med Rev.
2012;
26
(3):
252-61
-
Patient blood management.
Goodnough LT,
Shander A.
Anesthesiology.
2012;
116
(6):
1367-76
-
Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study.
Gutierrez MC,
Goodnough LT, Druzin M, Butwick AJ.
Int J Obstet Anesth.
2012;
21
(3):
230-5
-
Use of point-of-care testing for plasma therapy.
Goodnough LT,
Hill CC.
Transfusion.
2012:
52 Suppl 1
56S-64S
-
Age of blood as a limitation for transfusion: potential impact on blood inventory and availability.
Fontaine MJ,
Chung YT, Erhun F, Goodnough LT.
Transfusion.
2011;
51
(3):
662-3
-
Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ,
Kuo J, Chen G, Galel SA, Miller E, Sequeira F, Viele M, Goodnough LT, Tyan DB.
Transfusion.
2011;
51
(12):
2611-8
-
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines.
Goodnough LT,
Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M.
Br J Anaesth.
2011;
106
(1):
13-22
-
How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage.
Goodnough LT,
Shander A.
Blood.
2011;
117
(23):
6091-9
-
How we treat: transfusion medicine support of obstetric services.
Goodnough LT,
Daniels K, Wong AE, Viele M, Fontaine MF, Butwick AJ.
Transfusion.
2011;
51
(12):
2540-8
-
Quality management in the transfusion service: case studies in process improvement.
Goodnough LT,
Viele M, Fontaine M, Chua L, Ferrer Z, Jurado C, Quach P, Dunlap M, Arber DA.
Transfusion.
2011;
51
(3):
600-9
-
Detection, evaluation, and management of iron-restricted erythropoiesis.
Goodnough LT,
Nemeth E, Ganz T.
Blood.
2010;
116
(23):
4754-61
-
Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine.
Goodnough LT,
Shander AS.
Am J Hematol.
2010;
85
(11):
835-7
-
Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory.
Fontaine MJ,
Jurado C, Miller E, Viele M, Goodnough LT.
Transfusion.
2010;
50
(8):
1685-9
-
Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.
Logan AC,
Goodnough LT.
Hematology Am Soc Hematol Educ Program.
2010:
2010
153-9
-
A case of no pain and no gain from blood?
Shander A,
Goodnough LT.
Crit Care Med.
2009;
37
(6):
2104-5
-
Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion.
Goodnough LT,
Viele M, Fontaine MJ, Jurado C, Stone N, Quach P, Chua L, Chin ML, Scott R, Tokareva I, Tabb K, Sharek PJ.
Transfusion.
2009;
49
(7):
1321-8
-
Improving platelet supply chains through collaborations between blood centers and transfusion services.
Fontaine MJ,
Chung YT, Rogers WM, Sussmann HD, Quach P, Galel SA, Goodnough LT, Erhun F.
Transfusion.
2009;
49
(10):
2040-7
-
Iron overload and toxicity: the hidden risk of multiple blood transfusions.
Shander A,
Cappellini MD, Goodnough LT.
Vox Sang.
2009;
97
(3):
185-97
-
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB,
Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
Transfusion.
2009;
49
(12):
2719-28
-
Retrospective analysis of transfusion outcomes in pregnant patients at a tertiary obstetric center.
Butwick AJ,
Aleshi P, Fontaine M, Riley ET, Goodnough LT.
Int J Obstet Anesth.
2009;
18
(4):
302-8
-
The new age of iron: evaluation and management of iron-restricted erythropoiesis.
Goodnough LT,
Semin Hematol.
2009;
46
(4):
325-7
-
Why an alternative to blood transfusion?
Shander A,
Goodnough LT.
Crit Care Clin.
2009;
25
(2):
261-77, Table of Contents
-
Do preoperative anemia and polycythemia affect clinical outcome in patients undergoing major surgery?
Shander A,
Goodnough LT.
Nat Clin Pract Cardiovasc Med.
2008;
5
(1):
20-1
-
Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis.
Reynolds MW,
Shibata A, Zhao S, Jones N, Fahrbach K, Goodnough LT.
Curr Med Res Opin.
2008;
24
(2):
497-505
-
The role of intravenous iron in anemia management and transfusion avoidance.
Auerbach M,
Goodnough LT, Picard D, Maniatis A.
Transfusion.
2008;
48
(5):
988-1000
-
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Fong T,
Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, Dipersio JF, Khoury HJ.
Biol Blood Marrow Transplant.
2007;
13
(10):
1201-6
-
Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients.
Boyd SD,
Stenard F, Lee DK, Goodnough LT, Esquivel CO, Fontaine MJ.
Liver Transpl.
2007;
13
(12):
1654-61
-
Blood management.
Goodnough LT,
Shander A.
Arch Pathol Lab Med.
2007;
131
(5):
695-701
-
Erythropoietin and iron-restricted erythropoiesis.
Goodnough LT,
Exp Hematol.
2007;
35
(4 Suppl 1):
167-72
-
How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol.
Burtelow M,
Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT.
Transfusion.
2007;
47
(9):
1564-72
-
Recombinant factor VIIa: safety and efficacy.
Goodnough LT,
Shander AS.
Curr Opin Hematol.
2007;
14
(5):
504-9
-
Transfusion triggers.
Goodnough LT,
Surgery.
2007;
142
(4 Suppl):
S67-70
-
Update on transfusion medicine.
Shander A,
Goodnough LT.
Pharmacotherapy.
2007;
27
(9 Pt 2):
57S-68S
-
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
Mintz PD,
Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG.
Transfusion.
2006;
46
(10):
1693-704
-
Anemia screening in elective surgery: definition, significance and patients' interests.
Shander A,
Javidroozi M, Goodnough LT.
Anesth Analg.
2006;
103
(3):
778-9; author reply 779-80
-
Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
Ross SD,
Allen IE, Henry DH, Seaman C, Sercus B, Goodnough LT.
Clin Ther.
2006;
28
(6):
801-31
-
Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations.
Dubois RW,
Goodnough LT, Ershler WB, Van Winkle L, Nissenson AR.
Curr Med Res Opin.
2006;
22
(2):
385-95
-
Objectives and limitations of bloodless medical care.
Shander A,
Goodnough LT.
Curr Opin Hematol.
2006;
13
(6):
462-70
-
The relevance of iron in erythropoietin-stimulated erythropoiesis.
Goodnough LT,
Semin Hematol.
2006;
43
(4 Suppl 6):
S3-8
-
Anemia of chronic disease.
Weiss G,
Goodnough LT.
N Engl J Med.
2005;
352
(10):
1011-23
-
Autologous blood donation.
Goodnough LT,
Anesthesiol Clin North America.
2005;
23
(2):
263-70, vi
-
Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.
Girgis M,
Hallemeier C, Blum W, Brown R, Lin HS, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, Dipersio J, Adkins D.
Blood.
2005;
105
(8):
3035-41
-
Detection, evaluation, and management of anemia in the elective surgical patient.
Goodnough LT,
Shander A, Spivak JL, Waters JH, Friedman AJ, Carson JL, Keating EM, Maddox T, Spence R.
Anesth Analg.
2005;
101
(6):
1858-61
-
Evidence-based and consensus recommendations for the non-approved use of recombinant human factor VIIa therapy
Shander A,
Goodnough LT, Ratko T, Matuszewski K, Cohn S, Diringer M, Edmunds H, Lawson J, MacLaren R, Ness P, Shere-Wolfe R, Dubois R.
Pharmacotherapeutics.
2005;
(30):
644-658
-
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
Devine SM,
Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF.
Bone Marrow Transplant.
2005;
36
(6):
531-8
-
Anemia and its clinical consequences in patients with chronic diseases.
Goodnough LT,
Nissenson AR.
Am J Med.
2004:
116 Suppl 7A
1S-2S
-
Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?
Young PP,
Uzieblo A, Trulock E, Lublin DM, Goodnough LT.
Transfusion.
2004;
44
(1):
67-72
-
Blood and blood conservation: a national perspective.
Goodnough LT,
J Cardiothorac Vasc Anesth.
2004;
18
(4 Suppl):
6S-11S
-
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
Zheng XL,
Kaufman RM, Goodnough LT, Sadler JE.
Blood.
2004;
103
(11):
4043-9
-
Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Hoerr AL,
Gao F, Hidalgo J, Tiwari D, Blum KA, Mathews V, Adkins DR, Blum W, Devine S, Vij R, Goodnough LT, Dipersio JF, Khoury HJ.
J Clin Oncol.
2004;
22
(22):
4561-6
-
Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
Goodnough LT,
Semin Hematol.
2004;
41
(1 Suppl 1):
25-9
-
Invited commentary.
Goodnough LT,
Shander A.
Ann Thorac Surg.
2004;
78
(5):
1554-5
-
Joint ASH and AABB educational session.
Goodnough LT,
Hewitt PE, Silliman CC.
Hematology Am Soc Hematol Educ Program.
2004:
457-72
-
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C,
Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.
Biol Blood Marrow Transplant.
2004;
10
(5):
310-9
-
Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature.
Wilson A,
Yu HT, Goodnough LT, Nissenson AR.
Am J Med.
2004:
116 Suppl 7A
50S-57S
-
Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
Hidalgo JD,
Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, Devine S, Graubert T, Blum W, Tomasson M, Goodnough LT, Vij R, DiPersio J, Khoury H.
Bone Marrow Transplant.
2004;
34
(7):
615-9
-
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.
McCullough J,
Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG.
Blood.
2004;
104
(5):
1534-41
-
Transfusion medicine service policies for recombinant factor VIIa administration.
Goodnough LT,
Lublin DM, Zhang L, Despotis G, Eby C.
Transfusion.
2004;
44
(9):
1325-31
-
The use of erythropoietin to increase red cell mass.
Goodnough LT,
Can J Anaesth.
2003 Jun-Jul;
50
(6 Suppl):
S10-8
-
Anemia: not just an innocent bystander?
Nissenson AR,
Goodnough LT, Dubois RW.
Arch Intern Med.
2003;
163
(12):
1400-4
-
Bloodless medicine: clinical care without allogeneic blood transfusion.
Goodnough LT,
Shander A, Spence R.
Transfusion.
2003;
43
(5):
668-76
-
Evolution in alternatives to blood transfusion.
Goodnough LT,
Shander A.
Hematol J.
2003;
4
(2):
87-91
-
Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation.
Khoury H,
Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, Dipersio JF.
Biol Blood Marrow Transplant.
2003;
9
(11):
714-21
-
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
Chohan R,
Vij R, Adkins D, Blum W, Brown R, Tomasson M, Devine S, Graubert T, Goodnough LT, DiPersio JF, Khoury H.
Br J Haematol.
2003;
123
(1):
110-3
-
Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.
Vij R,
Khoury H, Brown R, Goodnough LT, Devine SM, Blum W, Adkins D, DiPersio JF.
Bone Marrow Transplant.
2003;
32
(7):
703-7
-
Patient safety and blood transfusion: new solutions.
Dzik WH,
Corwin H, Goodnough LT, Higgins M, Kaplan H, Murphy M, Ness P, Shulman IA, Yomtovian R.
Transfus Med Rev.
2003;
17
(3):
169-80
-
Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study.
Blum W,
Khoury H, Lin HS, Vij R, Goodnough LT, Devine S, Dipersio J, Adkins D.
Biol Blood Marrow Transplant.
2003;
9
(6):
397-404
-
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
Linker C,
Anderlini P, Herzig R, Christiansen N, Somlo G, Bensinger W, Fay J, Lynch JP, Goodnough LT, Ashby M, Benyunes MC, Jones DV, Yang TA, Miller LL, Weaver C.
Biol Blood Marrow Transplant.
2003;
9
(6):
405-13
-
Risks of blood transfusion.
Goodnough LT,
Crit Care Med.
2003;
31
(12 Suppl):
S678-86
-
Transfusion medicine: looking to the future.
Goodnough LT,
Shander A, Brecher ME.
Lancet.
2003;
361
(9352):
161-9
-
[Autologous blood procurement--acute normovolemic hemodilution vs. preoperative autologous blood donation].
Goodnough LT,
Zentralbl Chir.
2003;
128
(6):
462-7
-
Acute normovolemic hemodilution.
Goodnough LT,
Vox Sang.
2002:
83 Suppl 1
211-5
-
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.
Bui JD,
Despotis GD, Trulock EP, Patterson GA, Goodnough LT.
J Thorac Cardiovasc Surg.
2002;
124
(4):
852-4
-
Indications for red cell transfusion.
Goodnough LT,
Vox Sang.
2002:
83 Suppl 1
7-9
-
Issues in the management of cancer-related thrombocytopenia.
Goodnough LT,
DiPersio JF.
Oncology (Williston Park).
2002;
16
(11):
1558-67; discussion 1570, 1572-4
-
Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
Blum W,
Brown R, Lin HS, Zehnbauer B, Khoury H, Goodnough LT, Westervelt P, Vij R, DiPersio J, Adkins D.
Biol Blood Marrow Transplant.
2002;
8
(11):
608-18
-
Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial.
Levy JH,
Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ.
J Thorac Cardiovasc Surg.
2002;
124
(1):
35-42
-
The rise and fall of preoperative autologous blood donation (editorial). Transfusion. 2001;41:1459-62.
Brecher ME,
Goodnough LT.
Transfusion.
2002;
42
(12):
1618-22
-
Treatment of critical bleeding in the future intensive care unit.
Goodnough LT,
Intensive Care Med.
2002:
28 Suppl 2
S221
-
Anemia, transfusion, and mortality.
Goodnough LT,
Bach RG.
N Engl J Med.
2001;
345
(17):
1272-4
-
Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
Uhlmann EJ,
Isgriggs E, Wallhermfechtel M, Goodnough LT.
Transfusion.
2001;
41
(8):
997-1000
-
Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
Goodnough LT,
Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S.
Blood.
2001;
98
(5):
1346-51
-
Thrombopoietin therapy increases platelet yields in healthy platelet donors.
Kuter DJ,
Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J.
Blood.
2001;
98
(5):
1339-45
-
Transfusion medicine : support of patients undergoing cardiac surgery.
Goodnough LT,
Despotis GJ.
Am J Cardiovasc Drugs.
2001;
1
(5):
337-51
-
Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
Khoury H,
Adkins D, Brown R, Vij R, Westervelt P, Trinkaus K, Goodnough LT, DiPersio JF.
Bone Marrow Transplant.
2000;
25
(11):
1197-201
-
Blood conservation in patients undergoing non-cardiac surgery.
Goodnough LT,
Monk TG.
Curr Opin Anaesthesiol.
2000;
13
(3):
365-70
-
Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial.
Brecher ME,
Goodnough LT.
Transfusion.
2000;
40
(3):
383-4
-
Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
Adkins DR,
Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, Vij R, DiPersio J.
Blood.
2000;
95
(11):
3605-12
-
Erythropoietin, iron, and erythropoiesis.
Goodnough LT,
Skikne B, Brugnara C.
Blood.
2000;
96
(3):
823-33
-
Innovations in allogeneic stem-cell transplantation.
DiPersio JF,
Khoury H, Haug J, Vij R, Adkins DR, Goodnough LT, Brown RA.
Semin Hematol.
2000;
37
(1 Suppl 2):
33-41
-
Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery.
Despotis GJ,
Goodnough LT.
Ann Thorac Surg.
2000;
70
(2 Suppl):
S20-32
-
Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
Adkins DR,
Abidi MH, Brown RA, Khoury H, Goodnough LT, Vij R, Westervelt P, DiPersio JF.
Bone Marrow Transplant.
2000;
26
(11):
1239-41
-
The case against universal WBC reduction (and for the practice of evidence-based medicine).
Goodnough LT,
Transfusion.
2000;
40
(12):
1522-7
-
A prospective randomized comparison of three blood conservation strategies for radical prostatectomy.
Monk TG,
Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ.
Anesthesiology.
1999;
91
(1):
24-33
-
A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty.
Goodnough LT,
Monk TG, Despotis GJ, Merkel K.
Vox Sang.
1999;
77
(1):
11-6
-
Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
Goodnough LT,
Ali S, Despotis G, Dynis M, DiPersio JF.
Vox Sang.
1999;
76
(1):
43-9
-
Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.
Brown RA,
Adkins D, Khoury H, Vij R, Goodnough LT, Shenoy S, DiPersio JF.
J Clin Oncol.
1999;
17
(3):
806-12
-
Optimal management of bleeding and transfusion in patients undergoing cardiac surgery.
Despotis GJ,
Skubas NJ, Goodnough LT.
Semin Thorac Cardiovasc Surg.
1999;
11
(2):
84-104
-
Prevalence of HLA sensitization in female apheresis donors.
Densmore TL,
Goodnough LT, Ali S, Dynis M, Chaplin H.
Transfusion.
1999;
39
(1):
103-6
-
The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling.
Brecher ME,
Goodnough LT, Monk T.
Transfusion.
1999;
39
(4):
396-402
-
Transfusion medicine. First of two parts--blood transfusion.
Goodnough LT,
Brecher ME, Kanter MH, AuBuchon JP.
N Engl J Med.
1999;
340
(6):
438-47
-
Transfusion medicine. Second of two parts--blood conservation.
Goodnough LT,
Brecher ME, Kanter MH, AuBuchon JP.
N Engl J Med.
1999;
340
(7):
525-33
-
What is a transfusion medicine specialist?
Goodnough LT,
Transfusion.
1999;
39
(9):
1031-3
-
Where does preoperative erythropoietin therapy count? A mathematical perspective.
Brecher ME,
Goodnough LT, Monk T.
Transfusion.
1999;
39
(4):
392-5
-
Acute normovolemic hemodilution.
Monk TG,
Goodnough LT.
Clin Orthop Relat Res.
1998;
(357):
74-81
-
Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose.
Goodnough LT,
Kuter D, McCullough J, Brecher ME.
J Clin Apher.
1998;
13
(3):
114-9
-
Compensatory eythropoiesis during routine autologous blood donation.
Goodnough LT,
Mercuriali F.
Transfusion.
1998;
38
(6):
613-5
-
Controversies in autologous blood procurement.
Goodnough LT,
Br J Anaesth.
1998:
81 Suppl 1
67-72
-
Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron.
Goodnough LT,
Marcus RE.
Vox Sang.
1998;
75
(2):
128-33
-
Erythropoietin therapy in the perioperative setting.
Goodnough LT,
Monk TG.
Clin Orthop Relat Res.
1998;
(357):
82-8
-
Future directions in utilization review: the role of transfusion algorithms.
Goodnough LT,
Despotis GJ.
Transfus Sci.
1998;
19
(1):
97-105
-
Guidelines for the treatment of preoperative anaemia with epoetin.
Goodnough LT,
BioDrugs.
1998;
10
(3):
183-91
-
Oxygen carriers as blood substitutes. Past, present, and future.
Goodnough LT,
Scott MG, Monk TG.
Clin Orthop Relat Res.
1998;
(357):
89-100
-
Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy.
Hogue CW,
Goodnough LT, Monk TG.
Transfusion.
1998;
38
(10):
924-31
-
The Collaborative Hospital Transfusion Study: variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery.
Churchill WH,
McGurk S, Chapman RH, Wallace EL, Bertholf MF, Goodnough LT, Kao KJ, Olson JD, Woodson RD, Surgenor DM.
Transfusion.
1998;
38
(6):
530-9
-
The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals.
Surgenor DM,
Churchill WH, Wallace EL, Rizzo RJ, McGurk S, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD.
Transfusion.
1998;
38
(2):
122-34
-
Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation.
Adkins D,
Brown R, Goodnough LT, Khoury H, Popovic W, DiPersio J.
Bone Marrow Transplant.
1998;
21
(1):
97-9
-
Blood substitutes: evolution and future applications.
Scott MG,
Kucik DF, Goodnough LT, Monk TG.
Clin Chem.
1997;
43
(9):
1724-31
-
Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests.
Ma Z,
Monk TG, Goodnough LT, McClellan A, Gawryl M, Clark T, Moreira P, Keipert PE, Scott MG.
Clin Chem.
1997;
43
(9):
1732-7
-
Erythropoietin therapy in patients undergoing cardiac operations.
Goodnough LT,
Despotis GJ, Parvin CA.
Ann Thorac Surg.
1997;
64
(6):
1579-80
-
Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.
Brown RA,
Adkins D, Goodnough LT, Haug JS, Todd G, Wehde M, Hendricks D, Ehlenbeck C, Laub L, DiPersio J.
J Clin Oncol.
1997;
15
(9):
3067-74
-
Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes.
Despotis GJ,
Joist JH, Goodnough LT.
Clin Chem.
1997;
43
(9):
1684-96
-
Relationship between leukocyte count and patient risk for excessive blood loss after cardiac surgery.
Despotis GJ,
Levine V, Goodnough LT.
Crit Care Med.
1997;
25
(8):
1338-46
-
Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements.
Despotis GJ,
Joist JH, Goodnough LT, Santoro SA, Spitznagel E.
J Thorac Cardiovasc Surg.
1997;
113
(3):
611-3
-
Autologous blood procurement in the surgical setting: lessons learned in the last 10 years.
Goodnough LT,
Monk TG, Brecher ME.
Vox Sang.
1996;
71
(3):
133-41
-
Current red blood cell transfusion practices.
Goodnough LT,
AACN Clin Issues.
1996;
7
(2):
212-220
-
Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study.
Surgenor DM,
Churchill WH, Wallace EL, Rizzo RJ, Chapman RH, McGurk S, Bertholf MF, Goodnough LT, Kao KJ, Koerner TA, Olson JD, Woodson RD.
Transfusion.
1996;
36
(6):
521-32
-
Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews.
Audet AM,
Goodnough LT, Parvin CA.
Int J Qual Health Care.
1996;
8
(1):
41-9
-
Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients.
Despotis GJ,
Levine V, Filos KS, Santoro SA, Joist JH, Spitznagel E, Goodnough LT.
Anesthesiology.
1996;
85
(6):
1311-23
-
Evaluation of complete blood count results from a new, on-site hemocytometer compared with a laboratory-based hemocytometer.
Despotis GJ,
Alsoufiev A, Hogue CW, Zoys TN, Goodnough LT, Santoro SA, Kater KM, Barnes P, Lappas DG.
Crit Care Med.
1996;
24
(7):
1163-7
-
Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infarction.
Goodnough LT,
Monk TG.
Am J Med.
1996;
101
(2A):
33S-37S
-
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
Price TH,
Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI.
Am J Med.
1996;
101
(2A):
22S-27S
-
Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: an analysis of cost and benefit.
Goodnough LT,
Monk TG, Sicard G, Satterfield SA, Allen B, Anderson CB, Thompson RW, Flye W, Martin K.
J Vasc Surg.
1996;
24
(2):
213-8
-
More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
Despotis GJ,
Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, Spitznagel E, Weitz JI, Goodnough LT.
Thromb Haemost.
1996;
76
(6):
902-8
-
Recurrent thrombosis of biventricular-support devices associated with accelerated intravascular coagulation and increased heparin requirements.
Despotis GJ,
Levine V, Alsoufiev A, Joist H, Goodnough LT, Pasque M.
J Thorac Cardiovasc Surg.
1996;
112
(2):
538-40
-
Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
Despotis GJ,
Alsoufiev AL, Spitznagel E, Goodnough LT, Lappas DG.
Ann Thorac Surg.
1996;
61
(3):
795-9
-
Stratifying patients preoperatively for transfusion outcomes.
Goodnough LT,
Ann Thorac Surg.
1996;
61
(1):
8-9
-
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial.
Price TH,
Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI.
Transfusion.
1996;
36
(1):
29-36
-
Utilization review for red cell transfusions. Are we just going through the motions?
Goodnough LT,
Audet AM.
Arch Pathol Lab Med.
1996;
120
(9):
802-3
-
Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy.
Monk TG,
Goodnough LT, Birkmeyer JD, Brecher ME, Catalona WJ.
Transfusion.
1995;
35
(7):
559-65
-
Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide.
Blume G,
Pestronk A, Goodnough LT.
Neurology.
1995;
45
(8):
1577-80
-
Aprotinin prolongs whole blood activated partial thromboplastin time but not whole blood prothrombin time in patients undergoing cardiac surgery.
Despotis GJ,
Alsoufiev A, Goodnough LT, Lappas DG.
Anesth Analg.
1995;
81
(5):
919-24
-
Blood conservation strategies to minimize allogeneic blood use in urologic surgery.
Monk TG,
Goodnough LT.
Am J Surg.
1995;
170
(6A Suppl):
69S-73S
-
Effect of aprotinin on activated clotting time, whole blood and plasma heparin measurements.
Despotis GJ,
Joist JH, Joiner-Maier D, Alsoufiev AL, Triantafillou AN, Goodnough LT, Santoro SA, Lappas DG.
Ann Thorac Surg.
1995;
59
(1):
106-11
-
Establishing practice guidelines for surgical blood management.
Goodnough LT,
Despotis GJ.
Am J Surg.
1995;
170
(6A Suppl):
16S-20S
-
On the need for improved transfusion indicators in cardiac surgery.
Goodnough LT,
Despotis GJ, Hogue CW, Ferguson TB.
Ann Thorac Surg.
1995;
60
(2):
473-80
-
Recombinant growth factors.
Goodnough LT,
Anderson KC.
Transfus Sci.
1995;
16
(1):
45-62
-
The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: the effects of age and gender.
Goodnough LT,
Price TH, Parvin CA.
J Lab Clin Med.
1995;
126
(1):
57-64
-
The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for postoperative blood salvage and reinfusion.
Goodnough LT,
Verbrugge D, Marcus RE.
Am J Knee Surg.
1995;
8
(3):
83-7
-
The use of erythropoietin in the enhancement of autologous transfusion therapy.
Goodnough LT,
Curr Opin Hematol.
1995;
2
(3):
214-8
-
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy.
Goodnough LT,
Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI.
Transfusion.
1994;
34
(1):
66-71
-
Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy.
Goodnough LT,
Grishaber JE, Monk TG, Catalona WJ.
Anesth Analg.
1994;
78
(5):
932-7
-
Bacterial contamination of platelets at a university hospital: increased identification due to intensified surveillance.
Zaza S,
Tokars JI, Yomtovian R, Hirschler NV, Jacobs MR, Lazarus HM, Goodnough LT, Bland LA, Arduino MJ, Jarvis WR.
Infect Control Hosp Epidemiol.
1994;
15
(2):
82-7
-
Blood conservation and blood salvage
Goodnough LT,
Bodner M, Martin J.
J Int Care Med,.
1994;
(9):
86-92
-
Blood transfusion and blood conservation: cost and utilization issues.
Goodnough LT,
Bodner MS, Martin JW.
Am J Med Qual.
1994;
9
(4):
172-83
-
Clinical application of recombinant erythropoietin in the perioperative period.
Goodnough LT,
Hematol Oncol Clin North Am.
1994;
8
(5):
1011-20
-
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
Despotis GJ,
Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Spitznagel E, Cox JL, Lappas DG.
J Thorac Cardiovasc Surg.
1994;
108
(6):
1076-82
-
Cost-effective strategies for autologous blood procurement before surgery.
Goodnough LT,
Vox Sang.
1994:
67 Suppl 3
187-90
-
Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting.
Birkmeyer JD,
AuBuchon JP, Littenberg B, O'Connor GT, Nease RF, Nugent WC, Goodnough LT.
Ann Thorac Surg.
1994;
57
(1):
161-8; discussion 168-9
-
Discharge haematocrit as clinical indicator for blood transfusion audit in surgery patients.
Goodnough LT,
Vizmeg K, Riddell J, Soegiarso RW.
Transfus Med.
1994;
4
(1):
35-44
-
Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide.
Pestronk A,
Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee WC, Goodnough LT.
Neurology.
1994;
44
(11):
2027-31
-
Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy.
Goodnough LT,
Price TH, Parvin CA, Friedman KD, Vogler WR, Khan N, Sacher R, Johnston M, Wissel M, Ciavarella D.
Br J Haematol.
1994;
87
(4):
695-9
-
Guidelines for blood utilization review.
Stehling L,
Luban NL, Anderson KC, Sayers MH, Long A, Attar S, Leitman SF, Gould SA, Kruskall MS, Goodnough LT.
Transfusion.
1994;
34
(5):
438-48
-
Has recombinant human erythropoietin therapy minimized red-cell transfusions in hemodialysis patients?
Goodnough LT,
Strasburg D, Riddell J, Verbrugge D, Wish J.
Clin Nephrol.
1994;
41
(5):
303-7
-
In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.
Despotis GJ,
Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Zimmermann JJ, Lappas DG.
Anesth Analg.
1994;
79
(4):
670-4
-
Informed consent for blood transfusion as a transfusion medicine educational intervention.
Goodnough LT,
Hull AL, Kleinhenz ME.
Transfus Med.
1994;
4
(1):
51-5
-
Role of hematopoietic growth factors in transfusion medicine.
Goodnough LT,
Curr Opin Hematol.
1994;
1
(6):
462-70
-
The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery.
Despotis GJ,
Grishaber JE, Goodnough LT.
Transfusion.
1994;
34
(4):
290-6
-
The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
Goodnough LT,
Verbrugge D, Marcus RE, Goldberg V.
J Am Coll Surg.
1994;
179
(2):
171-6
-
The effect of recombinant human erythropoietin therapy on red cell expansion during autologous blood donation.
Goodnough LT,
Marcus RE.
Contemp Orthop.
1994;
29
(6):
430-4
-
The effect of recombinant human erythropoietin treatment on the endurance performance of Sprague-Dawley rats.
Verbrugge DJ,
Goodnough LT.
Scand J Clin Lab Invest.
1994;
54
(1):
55-9
-
The impact of autologous blood ordering and blood procurement practices on allogeneic blood exposure in elective orthopedic surgery patients.
Goodnough LT,
Vizmeg K, Verbrugge D.
Am J Clin Pathol.
1994;
101
(3):
354-7
-
The implications of cost-effectiveness for autologous blood procurement.
Goodnough LT,
Arch Pathol Lab Med.
1994;
118
(4):
333-4
-
The safety of recombinant human erythropoietin therapy in autologous blood donors.
Goodnough LT,
J Lab Clin Med.
1994;
124
(1):
17-8
-
The use of growth factors as alternatives to blood products
Goodnough LT,
Transfusion Science.
1994:
16
-
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets.
Yomtovian R,
Lazarus HM, Goodnough LT, Hirschler NV, Morrissey AM, Jacobs MR.
Transfusion.
1993 Nov-Dec;
33
(11):
902-9
-
Indications and guidelines for the use of hematopoietic growth factors.
Goodnough LT,
Anderson KC, Kurtz S, Lane TA, Pisciotto PT, Sayers MH, Silberstein LE.
Transfusion.
1993 Nov-Dec;
33
(11):
944-59
-
Blood conservation and blood transfusion practices: Flip sides of the same coin. Editorial.
Goodnough LT,
Ann Thor Surg.
1993;
(56):
3-4
-
Blood conservation and blood transfusion practices: flip sides of the same coin.
Goodnough LT,
Ann Thorac Surg.
1993;
56
(1):
3-4
-
Blood lost and blood transfused in coronary artery bypass graft operation as implications for blood transfusion and blood conservation strategies.
Goodnough LT,
Soegiarso RW, Geha AS.
Surg Gynecol Obstet.
1993;
177
(4):
345-51
-
Blood lost and transfused in patients undergoing elective orthopedic operation.
Goodnough LT,
Vizmeg K, Marcus RE.
Surg Gynecol Obstet.
1993;
176
(3):
235-8
-
Blood transfusions in hip fracture patients: implications for blood conservation programs.
Goodnough LT,
Riddell J, Verbrugge D, Marcus RE.
J Orthop Trauma.
1993;
7
(1):
47-51
-
Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive.
Pisciotto PT,
Anderson KC, Goodnough LT, Kurtz SR, Lane TA, Sayers MH, Silberstein LE.
Transfus Sci.
1993;
14
(3):
291-4
-
Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery.
Goodnough LT,
Soegiarso RW, Birkmeyer JD, Welch HG.
Am J Med.
1993;
94
(5):
509-14
-
Erythropoietin--does it increase the efficiency of autologous blood donation?
Goodnough LT,
Beitr Infusionsther.
1993:
29
240-50
-
Evaluating the safety and efficacy of pharmacologic alternatives to blood.
Goodnough LT,
Ann Thor Surg.
1993;
(56):
1004-1005
-
Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration.
Goodnough LT,
Riddell J, Lazarus H, Chafel TL, Prince G, Hendrix D, Yomtovian R.
Vox Sang.
1993;
65
(2):
103-7
-
The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement.
Birkmeyer JD,
Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B.
Transfusion.
1993;
33
(7):
544-51
-
The rationale for the use of recombinant human erythropoietin to facilitate autologous blood collection before elective surgery.
Goodnough LT,
Contrib To Nephrol.
1993;
(30):
401-409
-
The role of recombinant growth factors in transfusion medicine
Goodnough LT,
Br J Anaesth,.
1993;
(70):
80-86
-
The role of recombinant growth factors in transfusion medicine.
Goodnough LT,
Br J Anaesth.
1993;
70
(1):
80-6
-
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.
Jacobs C,
Lyman G, Velez-García E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L.
J Clin Oncol.
1992;
10
(2):
257-63
-
Autologous blood donation in nonorthopaedic surgical procedures as a blood conservation strategy.
Goodnough LT,
Saha P, Hirschler NV, Yomtovian R..
Vox Sang..
1992;
63
(2):
96-101
-
Designated blood requests in elective surgery (letter).
Goodnough LT,
Schuck JM.
Am J Surg.
1992;
(163):
366-367
-
Effect of autologous blood donation in patients undergoing elective spine surgery.
Goodnough LT,
Marcus RE.
Spine (Phila Pa 1976)..
1992;
Feb;17
(2):
172-5
-
Erythropoietin therapy as a surgical blood conservation intervention.
Goodnough LT,
Laboratory Medicine.
1992;
(23):
457-460
-
Identifying elective orthopedic surgical patients transfused with amounts of blood in excess of need: the transfusion trigger revisited.
Goodnough LT,
Verbrugge D, Vizmeg K, Riddell J.
Transfusion.
1992;
32
(7):
648-53
-
Leukocyte reduction in blood component therapy.
Lane TA,
Anderson KC, Goodnough LT, Kurtz S, Moroff G, Pisciotto PT, Sayers M, Silberstein LE.
Ann Intern Med.
1992;
117
(2):
151-62
-
Nonhemic prime in cardiopulmonary bypass. (reply to Letter).
Geha AS,
Goodnough LT.
Ann Thor Surg.
1992;
(53):
180
-
Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy.
Goodnough LT,
Price TH, Rudnick S, Soegiarso RW.
Transfusion.
1992;
32
(5):
441-5
-
Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs.
Goodnough LT,
Vizmeg K, Sobecks R, Schwarz A, Soegiarso W..
Vox Sang..
1992;
63
(2):
90-5
-
Prevalence and correlates of hospital-based autologous blood programs: a statewide survey.
Hull AL,
Neuhauser DV, Goodnough LT.
Am J Med Sci..
1992;
May;303
(5):
285-8
-
Prudent strategies for elective red blood cell transfusion.
Welch HG,
Meehan KR, Goodnough LT..
Ann Intern Med..
1992;
Mar 1;116
(5):
393-402
-
Reducing the risk for transfusion-transmitted cytomegalovirus infection.
Sayers MH,
Anderson KC, Goodnough LT, Kurtz SR, Lane TA, Pisciotto P, Silberstein LE..
Ann Intern Med..
1992;
Jan 1;116
(1):
55-62
-
Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting.
Lazarus HM,
Goodnough LT, Goldwasser E, Long G, Arnold JL, Strohl KP.
Bone Marrow Transplant.
1992;
10
(1):
71-5
-
Strategies for elective red cell transfusion (reply to letter).
Goodnough LT,
Welch HG, Audet AM.
Ann Int Med.
1992;
(117):
442
-
Teaching medical students concepts of informed consent within the framework of a transfusion medicine curriculum.
Goodnough LT,
Hull AL, Kleinhenz ME.
Acad Med..
1992;
May;67
(5):
348
-
Toward bloodless surgery: Erythropoietin in the surgical setting.
Goodnough LT,
Seminars In Oncol.
1992;
(19):
19-24
-
Toward bloodless surgery: erythropoietin therapy in the surgical setting.
Goodnough LT,
Semin Oncol..
1992;
Jun;19
(3 Suppl 8):
19-24
-
Utilization and efficacy of autologous blood predeposit in radical prostatectomy with lymphadenectomy: implications for blood conservation and physician education programs.
Goodnough LT,
Riddell J, Kursh E, Resnick MI.
Urology.
1992;
40
(3):
201-5
-
A new era in blood conservation (editorial)
Goodnough LT,
Geha AS.
Ann Thor Surg.
1991;
(51):
703-704
-
Blood transfusion in elective orthopaedic surgery: Issues related to informed consent.
Goodnough LT,
Marcus RE.
Perspectives in Orthopaedics.
1991;
(2):
104-118
-
Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow.
Goodnough LT,
Price TH, Rudnick S.
J Lab Clin Med..
1991;
Sep;118
(3):
289-96
-
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients.
Lazarus HM,
Cohen SB, Clegg DO, Menitove JE, Sorin SB, Hinkle S, Markenson JA, Saal S, Goodnough LT, Fleischmann RM..
Transfusion.
1991;
Feb; 31
(2):
122-8
-
The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group.
Goodnough LT,
Johnston MF, Toy PT.
JAMA..
1991;
Jan 2;265
(1):
86-90
-
Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease.
Anderson KC,
Goodnough LT, Sayers M, Pisciotto PT, Kurtz SR, Lane TA, Anderson CS, Silberstein LE.
Blood..
1991;
May 15;77
(10):
2096 - 102
-
"Homologous blood transfusion needs in elective orthopaedic surgery: Potential role of erythropoietin therapy. (Letter)
Goodnough LT,
Marcus RE.
N Engl J Med.
1990;
(322):
1158-1159
-
Autologous blood donation as a medical insurance policy (Letter)
Goodnough LT,
Cont Obstet Gynec.
1990;
(35):
127
-
Erythropoietin as a pharmacologic alternative to blood transfusion in the surgical patient.
Goodnough LT,
Transfus Med Rev..
1990;
Oct; 4
(4):
288-96
-
Erythropoietin as a pharmacologic alternative to homologous blood transfusion in the surgical patient
Goodnough LT,
Transfusion Medicine Reviews.
1990;
(4):
288-296
-
Erythropoietin therapy in autologous blood donors.
Goodnough LT.,
Prog Clin Biol Res..
1990;
(338):
105-12
-
Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks.
Goodnough LT,
Johnston MF, Ramsey G, Sayers MH, Eisenstadt RS, Anderson KC, Rutman RC, Silberstein LE.
Ann Thorac Surg..
1990;
Oct; 50
(4):
675-83
-
Identifying personnel to receive continuing medical education about appropriate use of blood transfusions.
Goodnough LT,
Hull AL, Brennan PF, Shah VA, Martin B.
Acad Med..
1990;
Oct; 65
(10):
661
-
Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
Goodnough LT,
Brittenham GM..
J Lab Clin Med..
1990;
Jan;115
(1):
28-35
-
Potential role of recombinant human erythropoietin in the peri-surgical setting.
Goodnough LT,
Int J Cell Cloning..
1990;
Jan;8
(Suppl 1):
203-10
-
Recombinant human erythropoietin therapy in autologous blood donors
Goodnough LT,
Progress In Clinical and Biological Research.
1990;
(338):
105-112
-
Risks, options, and informed consent for blood transfusion in elective surgery.
Goodnough LT,
Shuck JM..
Am J Surg. Review..
1990;
Jun;159
(6):
602-9
-
The impact of preoperative autologous blood donation on orthopaedic surgical practice.
Goodnough LT,
Shafron D, Marcus RE..
Vox Sang..
1990;
59
(2):
65-9
-
Utilization and effectiveness of autologous blood donation for arthroplastic surgery.
Goodnough LT,
Shafron D, Marcus RE..
Arthroplasty. 1990;5 Suppl:S89-94..
1990;
(5 Suppl):
Suppl: S89-94
-
A two-institution study of transfusion practice in 78 consecutive adult elective open-heart procedures.
Goodnough LT,
Johnston MF, Shah T, Chernosky A..
Am J Clin Pathol..
1989;
Apr; 91
(4):
468-72
-
Directed blood procurement does not benefit patients who are enrolled in an autologous blood predeposit program.
Goodnough LT,
Am J Clin Pathol..
1989;
Oct; 92
(4):
484-7
-
Effects of a CME program on physicians' transfusion practices.
Hull AL,,
Wasman J, Goodnough LT..
Acad Med..
1989;
Nov; 64
(11):
681-5
-
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.
Goodnough LT,
Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitove JE, et al..
N Engl J Med..
1989;
Oct 26;321
(17):
1163-8
-
Limitations to donating adequate autologous blood prior to elective orthopedic surgery.
Goodnough LT,
Wasman J, Corlucci K, Chernosky A..
Arch Surg..
1989;
Apr; 124
(4):
494-6
-
Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion.
Goodnough LT,
Bravo JR, Hsueh YS, Keating LJ, Brittenham GM.
Transfusion..
1989;
Nov-Dec;29
(9):
821-2
-
The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy.
Landefeld CS,
Anderson PA, Goodnough LT, Moir TW, Hom DL, Rosenblatt MW, Goldman L..
J Clin Epidemiol..
1989;
42
(8):
711-8
-
Autologous blood donation. (Letter)
Goodnough LT,
JAMA.
1988;
(259):
2404-2405
-
Thrombogenic toxicity of breast cancer treatment: Chemotherapy versus antineoplastic effect. (Letter)
Goodnough LT,
Pearson O.
N Engl J Med.
1988;
(319):
443
-
Autologous blood donation for elective surgery. Effect on physician transfusion behavior.
Wasman J,
Goodnough LT.
JAMA..
1987;
Dec 4;258
(21):
3135-7
-
Predeposited autologous blood for elective surgery. A national multicenter study.
Toy PT,
Strauss RG, Stehling LC, Sears R, Price TH, Rossi EC, Collins ML, Crowley JP, Eisenstaedt RS, Goodnough LT, et al..
N Engl J Med..
1987;
Feb 26;316
(9):
517-20
-
Preleukemia in Fanconi's anemia: hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesis.
Barton JC,
Parmley RT, Carroll AJ, Huang ST, Goodnough LT, Findley HW Jr, Ragab AH..
J Submicrosc Cytol..
1987;
Apr; 19
(2):
355-64
-
Reptilase time for ANLL with DIC. (letter)
Spitzer T,
Rosenzweig SE, Goodnough LT, Lazarus HM, and Herzig RH.
Sca nd J Haematol.
1986;
(36):
411-12
-
Histidine-rich glycoprotein and changes in the components of the fibrinolytic system after streptokinase therapy in patients with pulmonary thromboembolism.
Goodnough LT,
Saito H, Bell WR, Heimburger N..
Am J Hematol..
1985;
Jul; 19
(3):
245-53
-
Bovine aortic endothelial cells elaborate an inhibitor of the generation of lipopolysaccharide-stimulated human blood monocyte procoagulant activity.
Goodnough LT,
Kleinhenz ME, Goldsmith GH Jr, Ziats NP, Robertson AL Jr..
J Clin Invest..
1984;
Jul;74
(1):
75-81
-
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.
Goodnough LT,
Saito H, Manni A, Jones PK, Pearson OH..
Cancer..
1984;
Oct 1; 54
(7):
1264-8
-
Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver.
Saito H,
Hamilton SM, Tavill AS, Goodnough LT, Louis L, Angell A.
J Clin Invest..
1983;
Sep;72
(3):
948-54
-
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
Goodnough LT,
Saito H, Ratnoff OD.
Medicine (Baltimore)..
1983;
Jul; 62
(4):
248-55
-
Fibronectin levels in congenital thrombocytopenia: Schulman's syndrome. (letter)
Goodnough LT,
Saito H, Ratnoff OD.
N Engl J Med.
1982;
(306):
938-939
-
Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis. Possible implications for enhanced fibrinolysis.
Saito H,
Goodnough LT, Boyle JM, Heimburger N..
Am J Med..
1982;
Aug; 73
(2):
179-82
-
Specific binding of thrombin by human peripheral blood monocytes: possible role in the clearance of activated clotting factors from the circulation.
Goodnough LT,
Saito H.
J Lab Clin Med..
1982;
Jun;99
(6):
87384
-
Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.
Saito H,
Goodnough LT, Knowles BB, Aden DP..
Proc Natl Acad Sci U S A..
1982;
Sep; 79
(18):
5684-7
-
Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
Saito H,
Goodnough LT, Soria J, Soria C, Aznar J, España F..
N Engl J Med..
1981;
Oct 15;305
(16):
910-4
-
Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome.
Saito H,
Goodnough LT, Makker SP, Kallen RJ..
Am J Med..
1981;
70
(3):
531-4.
-
Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia.
Goodnough LT,
Muir WA.
Arch Intern Med..
1980;
140
(11):
1526-7
Navigation for This Section: Pathology
Find a Researcher
Help
